APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+6.37%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.92B
AUM Growth
+$3.92B
(+6%)
Cap. Flow
+$265M
Cap. Flow
% of AUM
6.75%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
133
New
20
Increased
42
Reduced
20
Closed
29
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$92.2M |
| 2 |
AstraZeneca
AZN
|
$84.8M |
| 3 |
Baxter International
BAX
|
$69.3M |
| 4 |
Stevanato
STVN
|
$64.3M |
| 5 |
Caribou Biosciences
CRBU
|
$59.1M |
Top Sells
| 1 |
Maravai LifeSciences
MRVI
|
$124M |
| 2 |
Medtronic
MDT
|
$66.4M |
| 3 |
Biogen
BIIB
|
$63.7M |
| 4 |
NeoGenomics
NEO
|
$61.7M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$55.7M |
Sector Composition
| 1 | Healthcare | 97.34% |
| 2 | Technology | 1.13% |
| 3 | Financials | 0.61% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
SPDR S&P Biotech ETF
XBI
$5.31B
| – | – |
0
| – | – |
|
|
WKME
127
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| – | – |
-150,000
| Closed | -$4.39M |
|
|
OMIC
128
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| – | – |
-50,000
| Closed | -$1.37M |
|
|
SYNH
129
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-175,000
| Closed | -$15.7M |
|
|
CLVS
130
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-271,726
| Closed | -$1.58M |
|
|
TRIL
131
DELISTED
Trillium Therapeutics Inc.
TRIL
| – | – |
-4,105,000
| Closed | -$39.8M |
|
|
KDMN
132
DELISTED
Kadmon Holdings, Inc.
KDMN
| – | – |
-9,294,600
| Closed | -$36M |
|
|
CMIIU
133
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
| – | – |
-330,000
| Closed | -$4.44M |
|